Physician profile
Jerry Nash
NPI 1801842646
$1,731.68
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,137 · 2020: $258 · 2021: $140 · 2022: $130 · 2023: $67.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $67.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $67.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $197.19 | 2022-2023 | Uplizna |
| Novartis Pharmaceuticals Corporation | $171.75 | 2019-2020 | |
| Genzyme Corporation | $134.20 | 2019 | |
| Emd Serono, INC. | $132.80 | 2019-2020 | |
| Mallinckrodt Enterprises LLC | $131.58 | 2019 | |
| Ucb, INC. | $125.68 | 2019 | |
| Supernus Pharmaceuticals, INC. | $118.86 | 2019 | |
| Medtronic USA, INC. | $110.97 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $97.55 | 2021 | |
| Mdd US Operations, LLC | $95.53 | 2019 | |
| Amgen INC. | $63.85 | 2019-2020 | |
| Allergan, INC. | $48.46 | 2019-2020 | |
| Lilly USA, LLC | $37.91 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $29.46 | 2020 | |
| Mallinckrodt Hospital Products INC. | $23.57 | 2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $23.30 | 2021 | |
| Sk Life Science, INC. | $22.33 | 2020 | |
| Bausch Health US, LLC | $22.28 | 2020 | |
| Saol Therapeutics INC. | $20.89 | 2019 | |
| Eisai INC. | $19.61 | 2020 | |
| Acadia Pharmaceuticals INC | $19.18 | 2019 | |
| Abbvie INC. | $18.73 | 2021 | |
| Adamas Pharmaceuticals, INC. | $18.27 | 2019 | |
| Akcea Therapeutics, INC. | $17.22 | 2020 | |
| Tanabe Pharma America, INC. | $16.50 | 2020 | |
| Vertical Pharmaceuticals, LLC | $14.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerry Nash listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.